U.S. Physical Therapy, Inc. Financials

Market Capitalization $1.35 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	101.47
Forward PE	30.79
Price to Sales TTM	$2.11
Price to Book MRQ	$2.79
Enterprise to Revenue	2.62
Enterprise to EBITDA	19.36

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	3.57%
Operating Margin	10.93%
Return on Assets TTM	4.24%
Return on Equity TTM	4.75%

Income Statement

Revenue TTM	$639,062,016
Revenue per Share TTM	$42.49
Quarterly Revenue Growth	12.00%
Gross Profit TTM	$125,858,000
EBITDA	$88,862,000
Net Income to Common TTM	$14,100,000
Diluted EPS TTM	$0.88
Quarterly Earnings Growth YoY	-28.40%

Balance Sheet

Total Cash MRQ	$118,332,000
Total Cash per Share MRQ	$7.84
Total Debt MRQ	$
Total Debt to Equity MRQ	37.92
Current Ratio MRQ	1.78
Book Value per Share MRQ	$32.02

Cash Flow

Operating Cash Flow TTM	$82,366,000
Levered Free Cash Flow TTM	$75,812,752

USPH Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	15,095,000
Float Shares	14,846,976
Avg 10 Volume	81,760
Avg 30 Volume	None
Shares Short	521,428
Short Ratio	5.14
Short % of Shares	4.16%
% Held by Insiders	1.57%
% Held by Institutions	104.86%

Stock Price Summary

Beta	1.39
Fifty Two Week Low	$76.18
Fifty Two Week High	$113.63
Fifty Two Week Change	-7.28%
Day 50 MA	$92.59
Day 200 MA	$92.22

Dividends and Splits

Forward Annual Dividend Rate	$1.76
Forward Annual Dividend Yield	1.97%
Trailing Annual Dividend Rate	$1.76
Trailing Annual Dividend Yield	1.97%
Payout Ratio	198.86%
Dividend Date	2024-12-06
Ex Dividend Date	2024-11-15
Last Split Factor
Last Split Date	2001-06-29